EFM
RVMD icon

E Fund Management’s Revolution Medicines RVMD Stock Holding History

E Fund Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Sell
2,907
-2,933
-50% -$428K 0.01% 246
2026
Q1 		$568K Buy
+5,840
New +$590K 0.02% 267
2025
Q2 		$628K Buy
17,075
+1,802
+12% +$69.2K 0.03% 203
2025
Q1 		$540K Sell
15,273
-56,014
-79% -$2.27M 0.03% 217
2024
Q4 		$3.12M Buy
71,287
+60,503
+561% +$3.05M 0.16% 77
2024
Q3 		$489K Sell
10,784
-490
-4% -$21.3K 0.03% 198
2024
Q2 		$438K Sell
11,274
-2,164
-16% -$80.9K 0.02% 188
2024
Q1 		$433K Sell
13,438
-6,094
-31% -$181K 0.03% 186
2023
Q4 		$560K Buy
19,532
+7,877
+68% +$189K 0.04% 136
2023
Q3 		$323K Sell
11,655
-5,814
-33% -$172K 0.02% 200
2023
Q2 		$467K Sell
17,469
-1,134
-6% -$27.8K 0.04% 122
2023
Q1 		$403K Buy
18,603
+6,162
+50% +$152K 0.03% 164
2022
Q4 		$296K Sell
12,441
-5,976
-32% -$127K 0.02% 237
2022
Q3 		$363K Buy
18,417
+6,612
+56% +$145K 0.03% 203
2022
Q2 		$230K Buy
+11,805
New +$230K 0.02% 276

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

E Fund Management's RVMD Position: Q2 2026 in Review

E Fund Management reduced its Revolution Medicines (RVMD) stake by 50% in Q2 2026, selling an estimated $428K and leaving 2,907 shares worth $544K. The position accounts for 0.01% of the portfolio, ranked #246.

E Fund Management first reported a position in RVMD in Q2 2022 and has held it in 15 quarters since. The position peaked at $3.12M in Q4 2024. 689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • E Fund Management held 2,907 shares of Revolution Medicines worth $544K as of Q2 2026.
  • E Fund Management sold 2,933 Revolution Medicines shares in Q2 2026, an estimated $428K.
  • Revolution Medicines made up 0.01% of E Fund Management's portfolio in Q2 2026, its #246 holding.
  • E Fund Management first reported a position in Revolution Medicines in Q2 2022 and has held it in 15 quarters since.
  • E Fund Management's Revolution Medicines position peaked at $3.12M in Q4 2024.
  • 689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.